Aehr Test Systems (AEHR)
(Real Time Quote from BATS)
$13.21 USD
+0.08 (0.61%)
Updated Sep 27, 2024 01:26 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Aehr Test Systems falls in the month of May.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 33.16 | 14.56 | 9.45 | -2.03 | -2.80 |
Depreciation/Amortization & Depletion | 1.36 | 0.45 | 0.31 | 0.31 | 0.38 |
Net Change from Assets/Liabilities | -14.38 | -7.19 | -9.56 | 0.32 | -0.56 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -18.39 | 2.20 | 1.31 | -1.30 | 0.96 |
Net Cash From Operating Activities | 1.76 | 10.01 | 1.51 | -2.70 | -2.02 |
Property & Equipment | -0.75 | -1.36 | -0.42 | -0.23 | -0.16 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 18.00 | -17.29 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 17.25 | -18.66 | -0.42 | -0.23 | -0.16 |
Uses of Funds
5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.14 | 7.32 | 27.16 | 0.56 | 0.49 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.68 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -1.40 | 1.40 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.14 | 7.32 | 25.76 | 1.96 | 2.17 |
Effect of Exchange Rate Changes | -0.04 | -0.04 | 0.05 | 0.12 | 0.02 |
Net Change In Cash & Equivalents | 19.11 | -1.36 | 26.90 | -0.85 | 0.01 |
Cash at Beginning of Period | 30.20 | 31.56 | 4.66 | 5.51 | 5.51 |
Cash at End of Period | 49.31 | 30.20 | 31.56 | 4.66 | 5.51 |
Diluted Net EPS | 1.12 | 0.50 | 0.34 | -0.09 | -0.12 |
Fiscal Year End for Aehr Test Systems falls in the month of May.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 33.16 | 9.29 | 10.76 | 4.67 |
Depreciation/Amortization & Depletion | NA | 1.36 | 0.99 | 0.62 | 0.14 |
Net Change from Assets/Liabilities | NA | -14.38 | -11.37 | -9.06 | -1.48 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -18.39 | 1.61 | 1.03 | 0.56 |
Net Cash From Operating Activities | NA | 1.76 | 0.53 | 3.36 | 3.90 |
Property & Equipment | NA | -0.75 | 17.30 | -0.44 | -0.28 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 18.00 | 0.00 | 18.00 | 18.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 17.25 | 17.30 | 17.56 | 17.72 |
Uses of Funds
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.14 | -0.28 | -0.37 | -0.69 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | -0.07 | 0.00 |
Net Cash from Financing Activities | NA | 0.14 | -0.28 | -0.44 | -0.69 |
Effect of Exchange Rate Changes | NA | -0.04 | -0.02 | -0.02 | -0.02 |
Net Change In Cash & Equivalents | NA | 19.11 | 17.53 | 20.46 | 20.90 |
Cash at Beginning of Period | NA | 30.20 | 30.20 | 30.20 | 30.20 |
Cash at End of Period | NA | 49.31 | 47.73 | 50.66 | 51.11 |
Diluted Net EPS | NA | 0.81 | -0.05 | 0.20 | 0.16 |